These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1703363)

  • 1. Distribution of FK 506 in plasma lipoproteins in transplant patients.
    Warty V; Venkataramanan R; Zendehrouh P; McKaveney T; Chao J; Todo S; Starzl T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):954-5. PubMed ID: 1703363
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
    Zeevi A; Eiras G; Burckart G; Jain A; Kragack A; Venkataramanan R; Todo S; Fung J; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1990 Feb; 22(1):60-3. PubMed ID: 1689902
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.
    Zeevi A; Eiras G; Kaufman C; Alessiani M; Demetris AJ; Abu-Elmagd K; Jain A; Warty V; Venkataramanan R; Burckart G
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1406-8. PubMed ID: 1703341
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.
    Loss M; Winkler M; Schneider A; Oldhafer K; Manns MP; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1006-7. PubMed ID: 8623210
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay of FK 506 in plasma.
    Cadoff EM; Venkataramanan R; Krajack A; Jain AS; Fung JJ; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):50-1. PubMed ID: 1689898
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
    Nalesnik MA; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1108-10. PubMed ID: 1703335
    [No Abstract]   [Full Text] [Related]  

  • 7. FK 506: an immunosuppressant for the 1990s?
    Macleod AM; Thomson AW
    Lancet; 1991 Jan; 337(8732):25-7. PubMed ID: 1702172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
    Claesson K; Mayer AD; Squifflet JP; Grabensee B; Eigler FW; Behrend M; Vanrenterghem Y; van Hooff J; Morales JM; Johnson RW; Buchholz B; Land W; Forsythe JL; Neumayer HH; Ericzon BG; Mühlbacher F
    Transplant Proc; 1998 Jun; 30(4):1292-4. PubMed ID: 9636524
    [No Abstract]   [Full Text] [Related]  

  • 9. FK 506.
    Sewing KF; Christians U
    Lancet; 1991 Feb; 337(8739):499. PubMed ID: 1704090
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
    Jensik SC
    Transplant Proc; 1998 Jun; 30(4):1216-8. PubMed ID: 9636494
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients.
    Venkiteswaran K; Sgoutas DS; Santanam N; Neylan JF
    Transpl Int; 2001 Dec; 14(6):405-10. PubMed ID: 11793038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of immunosuppressive agents on plasma lipoproteins after organ transplantation.
    Kasiske BL
    J Lab Clin Med; 1994 Sep; 124(3):318-9. PubMed ID: 7521894
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
    Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
    Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
    Van Thiel DH; Iqbal M; Jain A; Fung J; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):37-40. PubMed ID: 1689893
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between erythrocyte-to-plasma distribution ratio of cyclosporin and lymphocyte proliferation in renal transplant patients.
    Shibata N; Hoshino N; Minouchi T; Yamaji A
    Eur J Clin Pharmacol; 1997; 51(6):455-9. PubMed ID: 9112059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early infections in kidney transplant recipients under FK 506.
    Kusne S; Martin M; Shapiro R; Jordan M; Fung J; Alessiani M; Jain A; Todo S; Starzl T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):956-7. PubMed ID: 1703364
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)].
    Díaz M; Azanza JR; Sádaba B; López de Ocáriz A
    Rev Med Univ Navarra; 1995; 39(1):28-40. PubMed ID: 14735715
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication review: FK 506.
    Holechek MJ
    ANNA J; 1991 Apr; 18(2):199-200. PubMed ID: 1708982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
    Staschak S; Wagner S; Block G; Van Thiel DH; Jain A; Fung J; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):47-9. PubMed ID: 1689896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.